PharmaTelevision - Alan Lewis, 2011 President of LESI explains the importance of Intellectual property to world economy

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Alan Lewis, 2011 President of LESI explains the importance of Intellectual property to world economy

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Alan Lewis, 2011 President of LESI

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

LESI: Role and purpose

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London, in 2011. On this show I have Alan Lewis, who is the President of Licensing Executives Society International and also a Partner at Adams & Adams, based in Johannesburg in South Africa, welcome to the show.

Alan Lewis:

Good morning, lovely to be here with you, thank you for the invitation.

Fintan Walton:

Pleasure, the Licensing Executives Society International is a body that was formed out of the local LESI members, member states and plays an important role I suppose in ensuring that there is an international representation of the interests of the members at the national level, would that be correct sequence?

Alan Lewis:

That's absolutely correct, there are 32 national and regional societies within the LES family and LES International is an umbrella organization and the members of which are the national societies which tends to organize and coordinate and look after cross broader events and other things associated with intellectual property.

Fintan Walton:

In the end what is the purpose of LES?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Alan Lewis

President

Alan Lewis is President of LESI and is a partner of the prestigious South African intellectual property law firm Adams & Adams, in its Johannesburg office. Adams & Adams celebrated its centenary in 2008 and is now the leading and largest intellectual property practice in South Africa. Alan Lewis is a member of the firm's patent department and concentrates on filing, prosecution, litigation and transactional aspects in regard to patents, registered designs and copyright, both nationally and internationally. He has a BSc with Physics and Maths as majors, a BSc (Electrical Engineering) (cum laude) and a BProc law degree. He is a patent attorney and has been a partner of Adams & Adamssince 1977. He is also a notary public. He has been a member and actively involved in the Licensing Executives Society, and is now President of the Licensing Executives Society International , having been president of LES South Africa in 1994/95 and again in 2005/6 and a vice president of LESI from 2005 to 2007. He is a Certified Licensing Professional and has acted as an adviser to various African countries in regard to commercialization of intellectual property. In addition he was included in the 2010 IAM listing of the World's Leading Patent and Technology Licensing Lawyers. In his practice Alan Lewis has successfully litigated many high profile IP cases and lectured and examined South African candidate patent attorneys for a number of years. He has been involved in several due diligence investigations, in particular for Net 1 UEPS when it listed in the US. He is also the contributor for Trade Secrets throughout the World (published by Thomson West) in regard to South Africa and was a member of an expert group assisting UNCITRAL in formulating guidelines on security interests relating to intellectual property. He has also presented numerous papers at conferences and seminars in South Africa and overseas on a variety of IP and licensing issues and has conducted training courses in regard to the management of intellectual assets.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

LESI

The Licensing Executives Society International LESI is an association of 32 national and regional societies, each composed of men and women who have an interest in the transfer of technology, or licensing of intellectual property rights - from technical knowhow and patented inventions to software, copyright and trademarks.